September 21, 2009 – Edwards Lifesciences Corp. today announced new clinical data demonstrating 100 percent freedom from structural deterioration of the Edwards SAPIEN valve at 18 months, as well as positive midterm patient outcomes resulting from the application of learnings from earlier clinical programs.

September 21, 2009 — Anticipating a change in the practice of interventional cardiology, Medtronic Inc.

September 22, 2009 - At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting Royal Philips Electronics today announced that it will integrate the MAQUET ‘Magnus’ surgical table with Philips’ cardiovascular X-ray systems to create an efficient ‘hybrid operating room’ environment for a full range of minimally-invasive and open surgical procedures.

September 21, 2009 — W. L. Gore & Associates last week announced that several physicians recently presented interim data from ongoing GORE PROPATEN Vascular Graft studies to clinical audiences at the 2009 annual vascular meeting.

September 21, 2009 – IBA (Ion Beam Applications S.A.), a provider of PET radiopharmaceuticals, and Aposense Ltd., a developer of agents targeting apoptosis (programmed cell death) for molecular imaging and therapy, today announced an exclusive collaboration agreement for commercializing Aposense [18F]–ML-10, Aposense’s novel agent for molecular imaging of apoptosis.

September 21, 2009 — Minnow Medical recently announced it will be presenting interim clinical data regarding a novel technology to treat Peripheral Artery Disease (PAD) on Monday, Sept. 21. The presentation, led by James R. Margolis will take place at 11:58 a.m. in room 133.